194 related articles for article (PubMed ID: 28799271)
1. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
2. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
3. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
[TBL] [Abstract][Full Text] [Related]
5. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
6. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
7. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes in patients with multiple primary melanomas.
Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
[TBL] [Abstract][Full Text] [Related]
10. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
Eriksson H; Lyth J; Andersson TM
Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
[TBL] [Abstract][Full Text] [Related]
11. Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011).
Grossman D; Farnham JM; Hyngstrom J; Klapperich ME; Secrest AM; Empey S; Bowen GM; Wada D; Andtbacka RHI; Grossmann K; Bowles TL; Cannon-Albright LA
J Am Acad Dermatol; 2018 Aug; 79(2):238-244. PubMed ID: 29499295
[TBL] [Abstract][Full Text] [Related]
12. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
[TBL] [Abstract][Full Text] [Related]
13. Conditional recurrence-free survival in patients with primary stage I-II cutaneous malignant melanoma - a population-based study.
Lyth J
Melanoma Res; 2018 Dec; 28(6):637-640. PubMed ID: 29994850
[TBL] [Abstract][Full Text] [Related]
14. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous malignant melanoma in Swedish children and teenagers 1973-1992: a clinico-pathological study of 130 cases.
Sander B; Karlsson P; Rosdahl I; Westermark P; Boeryd B
Int J Cancer; 1999 Mar; 80(5):646-51. PubMed ID: 10048960
[TBL] [Abstract][Full Text] [Related]
16. Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations.
Gillgren P; Brattström G; Frisell J; Persson JO; Ringborg U; Hansson J
Melanoma Res; 2005 Apr; 15(2):125-32. PubMed ID: 15846146
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.
Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M
Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355
[TBL] [Abstract][Full Text] [Related]
18. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales.
Giles G; Staples M; McCredie M; Coates M
Melanoma Res; 1995 Dec; 5(6):433-8. PubMed ID: 8589618
[TBL] [Abstract][Full Text] [Related]
19. "Location of cutaneous malignant melanoma in Sweden 2004-2018 - mortality and sex differences".
Önefäldt D; Zommorodi S; Falk Delgado A
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3398-3405. PubMed ID: 35803850
[TBL] [Abstract][Full Text] [Related]
20. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
